PUBLICATIONS · 30545780
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet
- Publication date
- 2019 Jan 19
- First author
- Dimopoulos MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet. 2019 Jan 19;393(10168):204-205. doi: 10.1016/S0140-6736(18)33128-3.
- note
- Source null
- related pmid
- 30545778
- relationship
- Comment in
Authors and identifiers
- name
- Dimopoulos MA
- type
- Author
- name
- Gay F
- type
- Author
- name
- Schjesvold F
- type
- Author
- name
- Beksac M
- type
- Author
- name
- Hajek R
- type
- Author
- name
- Weisel KC
- type
- Author
- name
- Goldschmidt H
- type
- Author
- name
- Maisnar V
- type
- Author
- name
- Moreau P
- type
- Author
- name
- Min CK
- type
- Author
- name
- Pluta A
- type
- Author
- name
- Chng WJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dimopoulos MA
- type
- Author
- name
- Gay F
- type
- Author
- name
- Schjesvold F
- type
- Author
- name
- Beksac M
- type
- Author
- name
- Hajek R
- type
- Author
- name
- Weisel KC
- type
- Author
- name
- Goldschmidt H
- type
- Author
- name
- Maisnar V
- type
- Author
- name
- Moreau P
- type
- Author
- name
- Min CK
- type
- Author
- name
- Pluta A
- type
- Author
- name
- Chng WJ
- type
- Author
- bibliography ids
- nci-bib-da75231a0984d782ea5c290e
- book metadata
- content sha256
- e3ab9851ee51ecf471dc976378ac884bebdf83c215669021b99388ec2fe2d3c9
- document type
- citation
- dois
- 10.1016/S0140-6736(18)33003-4
- electronic publication date
- display
- 2018 Dec 10
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30545780
- immutable id
- pubmed:30545780@e3ab9851ee51ecf471dc976378ac884bebdf83c215669021b99388ec2fe2d3c9
- journal
- abbreviation
- Lancet
- issn electronic
- 1474-547X
- issn print
- 0140-6736
- issue
- 10168
- name
- Lancet (London, England)
- nlm unique id
- 2985213R
- pages
- 253-264
- volume
- 393
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet. 2019 Jan 19;393(10168):204-205. doi: 10.1016/S0140-6736(18)33128-3.
- note
- Source null
- related pmid
- 30545778
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 30545780
- provenance
- batch id
- 438b2803888025c6cf56
- provider
- NCBI PubMed ESummary
- record sha256
- 847c74db565c9127f5ac7f769a3c87eb90ae539fefae0a52a6f23ec08a9e3fa8
- response sha256
- 0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
- retrieved at
- 2026-09-09T23:47:36.359220+00:00
- publication date
- display
- 2019 Jan 19
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Preserved source evidence · Not medical advice
Triangle